The United States Food and Drug Administration (FDA) has listed indications for growth hormone therapy in pediatric and adult patients.


Pediatric patients:

(1) growth hormone deficiency

(2) short stature with chronic renal failure

(3) short stature secondary to Prader-Willi Syndrome

(4) short stature associated with Turner Syndrome

(5) small for gestational age (SGA) at birth who have not reached a normal height range by age 2

(6) idiopathic short stature (ISS) > 2.25 SD below mean in height and unlikely to catch up in growth


Adult patients:

(1) adults with growth hormone deficiency

(2) adults with AIDS wasting



(1) children with AIDS wasting


To read more or access our algorithms and calculators, please log in or register.